Italy’s antitrust regulator fined Novartis AG and Roche Holding AG 182.5 million euros ($251 million) for allegedly colluding to prevent the use of Roche’s Avastin cancer drug as a treatment for an eye disease.
Boston Scientific Corp. won’t begin a study of its hypertension treatment until it can analyze a failed effort by Medtronic Inc. and review its approach with U.S. regulators, Chief Executive Officer Michael Mahoney said.
Doctors and researchers should have access to information from clinical trials related to all uses of medicines on the market, U.K. lawmakers said in a report to influence the government’s purchasing decisions.
Teva Pharmaceutical Industries Ltd., the world’s biggest generic-drug maker, was accused by lawyers at a Nevada trial of putting profit ahead of the safety of colonoscopy patients who got the company’s Propofol anesthetic from reused vials.
Google-like searches of hospital medical records using English words and phrases found more patient injuries than the numerical billing codes used to rate quality of care, pointing toward a better way to highlight safety issues, a study found.